vimarsana.com

Page 34 - புதியது யார்க் ப்ரெஸ்பிடீரியந் மருத்துவமனை News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Evidence That Matters in Digital Health: A Look at NODE Health s Evidence Matters Awards Winners and Finalists

Evidence That Matters in Digital Health: A Look at NODE.Health’s Evidence Matters Awards Winners and Finalists By Staff 1 min ago NEW YORK, Apr. 27, 2021 /PRNewswire-PRWeb/ What does it take to generate evidence to demonstrate the validity of your digital medicine solution? NODE.Health’s Evidence Matters Awards 2020 competition highlighted different approaches to validating digital health solutions. Our winners and finalists were chosen based on the scientific rigor of their approach to evidence, likelihood to make an impact and originality of their solution. Based on their experiences, learn the steps that researchers can take to validate digital solutions. The winner of the 2020 Evidence Matters awards was Smileyscope, who created a gamified Virtual Reality (VR)-based solution to combat the fear of pediatric needles. To validate their solution, Smileyscope used a two-part approach. First, they conducted a rigorous systematic review and meta-analysis of existing VR-base

Evidence That Matters in Digital Health: A Look at NODE Health s Evidence Matters Awards Winners and Finalists

Evidence That Matters in Digital Health: A Look at NODE Health s Evidence Matters Awards Winners and Finalists
prweb.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prweb.com Daily Mail and Mail on Sunday newspapers.

GT Biopharma Announces the Appointments of Gregory Berk, M D to Chief Medical Officer and Jeffrey S Miller, M D to Consulting Chief Scientific Officer

Share this article Share this article BEVERLY HILLS, Calif., April 26, 2021 /PRNewswire/ GT Biopharma, Inc. (NASDAQ: GTBP), a clinical stage immuno-oncology company focused on developing innovative therapeutics based on the Company s proprietary natural killer (NK) cell engager, TriKE™ protein biologic technology platform, today announced the appointment of Gregory Berk, M.D., to the position of Chief Medical Officer. Dr. Berk has served as a Director on GT Biopharma s Board since November 2020, and resigns that post in conjunction with his appointment. The Company is also pleased to announce that Jeffrey S. Miller, M.D., who has supported GT Biopharma as the Company s Consulting Chief Medical Officer since August 2019, will become the Company s Consulting Chief Scientific Officer. Dr. Miller, with his colleagues at the University of Minnesota, is the inventor of the novel TriKE™ technology platform. Dr. Miller will continue his leadership role with respect to the design a

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.